Skip to main content

DON’T GET STUCK IN THE MIDDLE: Evidence-based Management of Eosinophilic Esophagitis (Regional)


Click here to complete your registration.

If you will be watching the webinar in a group setting, please note all group participants will need to register individually in order to complete the post-test and evaluation to receive credit.



  • Welcome and Introduction
  • Diagnosis of Eosinophilic Esophagitis
  • Management of Patients with EoE
  • Q & A Session and Activity Roundup

Despite its relative nascency, eosinophilic esophagitis (EoE) has quickly become a major cause of upper gastrointestinal morbidity with significant impacts on patient quality of life and an increasing incidence. Consensus guideline recommendations with specific diagnostic criteria are available. In addition, although no medications are currently FDA approved for treating EoE, guideline recommendations include the use of proton pump inhibitors and glucocorticosteroids. Despite this current guidance, recent EoE practice pattern studies of US-practicing gastroenterologists have identified a lack of familiarity with EoE management guidelines as well as practice gaps in diagnostic, treatment, and monitoring aspects of patient care, as well as a lack of shared decision-making between gastroenterologists and their patients with EoE, resulting in suboptimal management decisions. Additionally, multiple targeted therapies, i.e., anti-interleukins, S1P modulators, are in late-stage clinical development and are likely to impact the EoE therapeutic landscape in the near future.

The CME program, “Don’t Get Stuck In The Middle: Evidence-based Management of Eosinophilic Esophagitis” will provide expert-led discussions on current guideline recommendations for diagnosis, treatment, and monitoring of patients with EoE, clinical evidence of emerging EoE therapies, and strategies for implementing shared decision-making in EoE management.

Ikuo Hirano, MD
Professor of Medicine
Northwestern University Feinberg School of Medicine
Chicago, IL

Jonathan M. Spergel, MD, PhD
Professor of Pediatrics
Chief, Allergy Section
Stuart E. Starr Chair in Pediatrics
Director of Center for Pediatric Eosinophilic Disease
The Children's Hospital of Philadelphia
Perelman School of Medicine at Univ. of Pennsylvania
Philadelphia, PA

This activity is intended for gastroenterologists and other clinicians involved in the manage patients with EoE.

At the conclusion of this activity, participants should be able to:
  • Use recommended criteria when making the diagnosis of eosinophilic esophagitis
  • Treat and monitor patients with eosinophilic esophagitis based on current guidelines and evidence
  • Implement shared decision-making to reach management decisions that meet the clinical and personal needs of patients with EoE
  • Assess the safety and efficacy of emerging therapies for eosinophilic esophagitis

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

The Potomac Center for Medical Education designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

For questions regarding CME credit or the evaluation, please email

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

To receive CME credit and/or MOC points, you MUST pass the post-test and complete the evaluation. For ABIM MOC points, your information will be shared with the ABIM through PCME’s ACCME Program and Activity Reporting System (PARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Continuing Certification Activities through the ABMS Continuing Certification Directory, Don't Get Stuck in the Middle: Evidence Based Management of Eosinophilic Esophagitis has met the requirements as a Part II CME Activity (apply toward general CME requirement) for the following ABMS Member Boards:

ABMS MOC Part II CME Activity
Family Medicine

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Integrity and Independence in Accredited CE, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other relevant professional organizations, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of an accredited continuing education program provided by the Potomac Center for Medical Education are required to disclose to PCME all financial relationships with any ineligible company within the past 24 months. All financial relationships reported are identified as relevant and mitigated by PCME in accordance with the Standards for Integrity and Independence in Accredited CE in advance of delivery of the activity to learners. The content of the activity is vetted by PCME to assure objectivity and that the activity is free of commercial bias. All relevant financial relationships will be mitigated by PCME.

Disclosure and mitigation information will be made known to the participants prior to the start of the activity.

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

To ensure your computer is compatible for the live event, please perform a system check by clicking on the link or by typing it into your internet browser. Please perform the system check on the same computer you will use for the live event. If your computer is compatible, you will receive a confirmation message on your screen and hear audio. Otherwise, please contact the Help Desk to resolve any issues.


  • 1.4 GHz Intel Pentium 4 or faster processor (or equivalent)
  • Windows 10, 8.1 (32-bit/64-bit), Windows 7 (32-bit/64-bit)
  • 512 MB of RAM (1 GB recommended)
  • Microsoft Internet Explorer 11 or later, Windows Edge browser, Mozilla Firefox, and Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Mozilla Firefox (v65.0 & above), and Edge (v42.0 & above)
  • 1.83 GHz Intel Core Duo or faster processor
  • 512 MB RAM (1 GB recommended)
  • Mac OS X 10.12, 10.13 and 10.14
  • Mozilla Firefox, Apple Safari, Google Chrome
  • For HTML Client - Google Chrome (v70.0 & above), Apple Safari (v12.0 & above), and Mozilla Firefox (v65.0 & above)
  • The Adobe Connect app for iOS and Android requires Adobe Connect Server version 8.2 or later
  • Some features may not be enabled in all Adobe Connect meetings if one is using an Adobe Connect Server older than version 9.4.2 (required for Custom pods)
  • Google Android 4.4 or later
  • Apple iOS: iOS 8.1.2 or later

DSL/cable (wired connection recommended)

There is no fee for this activity. To receive credit, participants must register, view the live CME/MOC activity in its entirety, and then complete the post-test, with a score of 70% or better, and evaluation. The estimated time for completion of this activity is one hour. To receive a certificate, participants must demonstrate mastery of the presented material via the post-test. Participants are allowed to take the post-test multiple times.

In collaboration with 

Jointly provided by the Potomac Center for Medical Education and Rockpointe

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme.

PCME Privacy Policy